Please login (Members) to view content or
(Nonmembers) this article.
No votes yet

Implementation of Intraperitoneal Chemotheraphy for the Treatment of Ovarian Cancer

Catherine Hydzik
CJON 2007, 11(2), 221-225 DOI: 10.1188/07.CJON.221-225

In January 2006, a clinical announcement made by the National Cancer Institute suggested that intraperitoneal chemotherapy become standard care for patients with newly diagnosed stage III, optimally debulked epithelial ovarian cancer. Intraperitoneal chemotherapy is new to many healthcare providers (i.e., physicians, nurses, and pharmacists). This article will discuss how to implement intraperitoneal chemotherapy in practice. Education and experience are the keys to successful implementation.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or